Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO)

NCT01391325 is registered in ClinicalTrials.gov with Ardea Biosciences, Inc. as lead sponsor.

NCT NCT01391325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01391325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO)
Lead sponsor
Ardea Biosciences, Inc.
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2011
Completion date
March 31, 2013
Enrollment
1,735 (actual)
Sites
173

Conditions

As the registry lists them; a condition with its own page is linked.

gout